Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas

Clinical trial NCT05400109 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05400109
Sponsor: David Wald
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma

Start date: 2023-04-26
Primary completion: 2026-10-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.